237 related articles for article (PubMed ID: 20417255)
1. MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons.
Gouty S; Brown JM; Rosenberger J; Cox BM
Neuroscience; 2010 Aug; 169(1):269-78. PubMed ID: 20417255
[TBL] [Abstract][Full Text] [Related]
2. Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease.
Arcuri L; Viaro R; Bido S; Longo F; Calcagno M; Fernagut PO; Zaveri NT; Calò G; Bezard E; Morari M
Neurobiol Dis; 2016 May; 89():55-64. PubMed ID: 26804029
[TBL] [Abstract][Full Text] [Related]
3. Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression.
Brown JM; Gouty S; Iyer V; Rosenberger J; Cox BM
J Neurochem; 2006 Jul; 98(2):495-505. PubMed ID: 16749908
[TBL] [Abstract][Full Text] [Related]
4. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems.
Norton CS; Neal CR; Kumar S; Akil H; Watson SJ
J Comp Neurol; 2002 Mar; 444(4):358-68. PubMed ID: 11891648
[TBL] [Abstract][Full Text] [Related]
5. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
Marti M; Mela F; Veronesi C; Guerrini R; Salvadori S; Federici M; Mercuri NB; Rizzi A; Franchi G; Beani L; Bianchi C; Morari M
J Neurosci; 2004 Jul; 24(30):6659-66. PubMed ID: 15282268
[TBL] [Abstract][Full Text] [Related]
6. Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned rats.
Di Benedetto M; Cavina C; D'Addario C; Leoni G; Candeletti S; Cox BM; Romualdi P
Neuropharmacology; 2009 Mar; 56(4):761-7. PubMed ID: 19162046
[TBL] [Abstract][Full Text] [Related]
7. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Hayley S; Crocker SJ; Smith PD; Shree T; Jackson-Lewis V; Przedborski S; Mount M; Slack R; Anisman H; Park DS
J Neurosci; 2004 Feb; 24(8):2045-53. PubMed ID: 14985447
[TBL] [Abstract][Full Text] [Related]
8. Differential Modulation of Ventral Tegmental Area Circuits by the Nociceptin/Orphanin FQ System.
Driscoll JR; Wallace TL; Mansourian KA; Martin WJ; Margolis EB
eNeuro; 2020; 7(5):. PubMed ID: 32747458
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of δ opioid receptor and blockade of nociceptin/orphanin FQ receptor synergistically attenuate parkinsonism.
Mabrouk OS; Viaro R; Volta M; Ledonne A; Mercuri N; Morari M
J Neurosci; 2014 Sep; 34(39):12953-62. PubMed ID: 25253844
[TBL] [Abstract][Full Text] [Related]
10. Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease.
Marti M; Mela F; Fantin M; Zucchini S; Brown JM; Witta J; Di Benedetto M; Buzas B; Reinscheid RK; Salvadori S; Guerrini R; Romualdi P; Candeletti S; Simonato M; Cox BM; Morari M
J Neurosci; 2005 Oct; 25(42):9591-601. PubMed ID: 16237164
[TBL] [Abstract][Full Text] [Related]
11. Rat ventral midbrain dopamine neurons express the orphanin FQ/nociceptin receptor ORL-1.
Maidment NT; Chen Y; Tan AM; Murphy NP; Leslie FM
Neuroreport; 2002 Jul; 13(9):1137-40. PubMed ID: 12151756
[TBL] [Abstract][Full Text] [Related]
12. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
Masilamoni GJ; Groover O; Smith Y
Neurobiol Dis; 2017 Apr; 100():9-18. PubMed ID: 28042095
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
[TBL] [Abstract][Full Text] [Related]
14. Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice.
Mabrouk OS; Marti M; Morari M
Neuroscience; 2010 Mar; 166(1):40-8. PubMed ID: 20006677
[TBL] [Abstract][Full Text] [Related]
15. Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease.
Marti M; Sarubbo S; Latini F; Cavallo M; Eleopra R; Biguzzi S; Lettieri C; Conti C; Simonato M; Zucchini S; Quatrale R; Sensi M; Candeletti S; Romualdi P; Morari M
Mov Disord; 2010 Aug; 25(11):1723-32. PubMed ID: 20589874
[TBL] [Abstract][Full Text] [Related]
16. Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates.
Swanson C; Emborg M
Neurol Res; 2014 Jul; 36(7):634-46. PubMed ID: 24620964
[TBL] [Abstract][Full Text] [Related]
17. VTA neurons show a potentially protective transcriptional response to MPTP.
Phani S; Gonye G; Iacovitti L
Brain Res; 2010 Jul; 1343():1-13. PubMed ID: 20462502
[TBL] [Abstract][Full Text] [Related]
18. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.
Gnanalingham KK; Milkowski NA; Smith LA; Hunter AJ; Jenner P; Marsden CD
Eur J Pharmacol; 1995 Apr; 277(2-3):235-41. PubMed ID: 7493614
[TBL] [Abstract][Full Text] [Related]
19. Cocaine Selectively Reorganizes Excitatory Inputs to Substantia Nigra Pars Compacta Dopamine Neurons.
Beaudoin GMJ; Gomez JA; Perkins J; Bland JL; Petko AK; Paladini CA
J Neurosci; 2018 Jan; 38(5):1151-1159. PubMed ID: 29263240
[TBL] [Abstract][Full Text] [Related]
20. Distribution of nociceptin/orphanin FQ precursor protein and receptor in brain and spinal cord: a study using in situ hybridization and X-gal histochemistry in receptor-deficient mice.
Houtani T; Nishi M; Takeshima H; Sato K; Sakuma S; Kakimoto S; Ueyama T; Noda T; Sugimoto T
J Comp Neurol; 2000 Aug; 424(3):489-508. PubMed ID: 10906715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
